All investment Cases
Capital raises and 2023 results among the healthcare news for the week
NORDIC | BIOTECH & HEALTHCARE Your insights into listed Danish & Nordic biotech & healthcare stocks. The Nordic biotech and
12. February 2024
We have decades of experience in analyzing small and mid-cap stocks as well as disseminating this information to retail investors. With investment cases, we provide free information on investment opportunities within the segment of Nordic small and mid-caps companies for primarily a Nordic investing audience.
If you want to contact us directly, find contact details for the individual employee under Line Up.
NORDIC | BIOTECH & HEALTHCARE Your insights into listed Danish & Nordic biotech & healthcare stocks. The Nordic biotech and
Most of the Nordic impact sectors were in positive territory with the food & beverage on top. A farming robotics
Curasight is off to a great start in 2024 with a milestone payment from Curium. After a whirlwind 2023 with
Nordic impact sectors have started well in 2024. Especially the CO2 and Carbon Capture sector, and companies focusing on energy
2023 was another eventful year for the Nordic healthcare stocks with plenty of opportunities amid an index loss of 20%.
The Nordic impact stocks had a difficult 2023 with share price declines across the board. Positive investments were few, but
In the past week, the Nordic impact sectors were driven by increased optimism. Many stocks delivered double digit returns. We
Nordic | Biotech & Healthcare Your insights to listed Danish & Nordic biotech & healthcare stocks. We keep you updated
Kapital Partner performs or has within the last 12 months performed corporate finance, market relations, investor relations, Certified Adviser or other advisory activities for the following listed companies: NORD.investments, Biosergen, InterMail, Pila Pharma, Hypefactors, Curasight, Evaxion, Re-Match, Audientes, Mdundo.com, Nexcom.
Del indlægget på sociale media eller på email.